CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine. (Q51614178)
Jump to navigation
Jump to search
scientific article published on 9 July 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine. |
scientific article published on 9 July 2015 |
Statements
CYP2C19 Phenoconversion by Routinely Prescribed Proton Pump Inhibitors Omeprazole and Esomeprazole: Clinical Implications for Personalized Medicine. (English)
1 reference
Martin Klieber
1 reference
Silvia Hofstaetter
1 reference
Beate Beer
1 reference
Martin Neururer
1 reference
Anton Amann
1 reference
Hannes Alber
1 reference
Anil Modak
1 reference
9 July 2015
1 reference
354
1 reference
3
1 reference
426-430
1 reference